Early prediction of nonresponders to treatment with interferon alpha 2B and Ribavirin in patients with chronic hepatitis C.

被引：0
|
作者：
Liu, LWC
Tomlinson, G
Mazulli, T
Heathcote, J
机构：
[1] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Epidemiol, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Microbiol, Toronto, ON, Canada
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
792
引用
收藏
页码：357A / 357A
页数：1
相关论文
共 50 条
  • [1] Early prediction of nonresponders to treatment with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Liu, LWC
    Tomlinson, G
    Mazzulli, T
    Murray, A
    Heathcote, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (08): : 483 - 487
  • [2] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [3] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [4] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [5] Daily administration of interferon alpha 2b and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Carrara, PD
    Arpe, P
    Maggi, F
    Vatteroni, ML
    Bendinelli, M
    Maltinti, G
    Marchi, S
    HEPATOLOGY, 1999, 30 (04) : 627A - 627A
  • [6] Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone
    Demir, K
    Kaymakoglu, S
    Dincer, D
    Tuncer, I
    Durakoglu, Z
    Karaca, C
    Besisik, F
    Cakaloglu, Y
    Okten, A
    JOURNAL OF HEPATOLOGY, 2001, 34 : 171 - 171
  • [7] High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C
    Moskovitz, DN
    Manoharan, P
    Heathcote, EJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (08): : 479 - 482
  • [8] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [9] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [10] Alfa interferon 2b and Ribavirin for treatment of patients with chronic hepatitis C who have failed alpha interferon 2b as single therapy.
    Blanchard, D
    Reed, T
    Freeman, S
    Weiner, K
    Bader, T
    HEPATOLOGY, 1998, 28 (04) : 284A - 284A
12345